Literature DB >> 33853956

Infection of Bronchial Epithelial Cells by the Human Adenoviruses A12, B3, and C2 Differently Regulates the Innate Antiviral Effector APOBEC3B.

Noémie Lejeune1, Florian Poulain1, Kévin Willemart1, Zoé Blockx1, Sarah Mathieu1, Nicolas A Gillet1.   

Abstract

Human adenoviruses (HAdVs) are a large family of DNA viruses that include more than 100 genotypes divided into seven species (A to G) and induce respiratory tract infections, gastroenteritis, and conjunctivitis. Genetically modified adenoviruses are also used as vaccines, gene therapies, and anticancer treatments. The APOBEC3s are a family of cytidine deaminases that restrict viruses by introducing mutations in their genomes. Viruses developed different strategies to cope with the APOBEC3 selection pressure, but nothing is known on the interplay between the APOBEC3s and the HAdVs. In this study, we focused on three HAdV strains: the B3 and C2 strains, as they are very frequent, and the A12 strain, which is less common but is oncogenic in animal models. We demonstrated that the three HAdV strains induce a similar APOBEC3B upregulation at the transcriptional level. At the protein level, however, APOBEC3B is abundantly expressed during HAdV-A12 and -C2 infection and shows a nuclear distribution. On the contrary, APOBEC3B is barely detectable in HAdV-B3-infected cells. APOBEC3B deaminase activity is detected in total protein extracts upon HAdV-A12 and -C2 infection. Bioinformatic analysis demonstrates that the HAdV-A12 genome bears a stronger APOBEC3 evolutionary footprint than that of the HAdV-C2 and HAdV-B3 genomes. Our results show that HAdV infection triggers the transcriptional upregulation of the antiviral innate effector APOBEC3B. The discrepancies between the APOBEC3B mRNA and protein levels might reflect the ability of some HAdV strains to antagonize the APOBEC3B protein. These findings point toward an involvement of APOBEC3B in HAdV restriction and evolution. IMPORTANCE The APOBEC3 family of cytosine deaminases has important roles in antiviral innate immunity and cancer. Notably, APOBEC3A and APOBEC3B are actively upregulated by several DNA tumor viruses and contribute to transformation by introducing mutations in the cellular genome. Human adenoviruses (HAdVs) are a large family of DNA viruses that cause generally asymptomatic infections in immunocompetent adults. HAdVs encode several oncogenes, and some HAdV strains, like HAdV-A12, induce tumors in hamsters and mice. Here, we show that HAdV infection specifically promotes the expression of the APOBEC3B gene. We report that infection with the A12 strain induces a strong expression of an enzymatically active APOBEC3B protein in bronchial epithelial cells. We provide bioinformatic evidence that HAdVs' genomes and notably the A12 genome are under APOBEC3 selection pressure. Thus, APOBEC3B might contribute to adenoviral restriction, diversification, and oncogenic potential of particular strains.

Entities:  

Keywords:  APOBEC3; APOBEC3B; HAdV-A12; HAdV-B3; HAdV-C2; adenoviruses; cytidine deaminase; innate immunity

Mesh:

Substances:

Year:  2021        PMID: 33853956      PMCID: PMC8315923          DOI: 10.1128/JVI.02413-20

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  92 in total

1.  Genetic editing of herpes simplex virus 1 and Epstein-Barr herpesvirus genomes by human APOBEC3 cytidine deaminases in culture and in vivo.

Authors:  Rodolphe Suspène; Marie-Ming Aynaud; Stefanie Koch; David Pasdeloup; Marc Labetoulle; Barbara Gaertner; Jean-Pierre Vartanian; Andreas Meyerhans; Simon Wain-Hobson
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  A viral mechanism for remodeling chromatin structure in G0 cells.

Authors:  Mrinal K Ghosh; Marian L Harter
Journal:  Mol Cell       Date:  2003-07       Impact factor: 17.970

3.  Molecular evolution of human species D adenoviruses.

Authors:  Christopher M Robinson; Donald Seto; Morris S Jones; David W Dyer; James Chodosh
Journal:  Infect Genet Evol       Date:  2011-05-05       Impact factor: 3.342

4.  Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.

Authors:  Ann M Sheehy; Nathan C Gaddis; Jonathan D Choi; Michael H Malim
Journal:  Nature       Date:  2002-07-14       Impact factor: 49.962

5.  Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction.

Authors:  Eric W Refsland; Mark D Stenglein; Keisuke Shindo; John S Albin; William L Brown; Reuben S Harris
Journal:  Nucleic Acids Res       Date:  2010-03-22       Impact factor: 16.971

6.  Simian virus 40 infection disrupts p130-E2F and p107-E2F complexes but does not perturb pRb-E2F complexes.

Authors:  C S Sullivan; A E Baker; J M Pipas
Journal:  Virology       Date:  2004-03-15       Impact factor: 3.616

Review 7.  Adenovirus vectors for gene therapy, vaccination and cancer gene therapy.

Authors:  William S M Wold; Karoly Toth
Journal:  Curr Gene Ther       Date:  2013-12       Impact factor: 4.391

8.  Structural determinants of APOBEC3B non-catalytic domain for molecular assembly and catalytic regulation.

Authors:  Xiao Xiao; Hanjing Yang; Vagan Arutiunian; Yao Fang; Guillaume Besse; Cherie Morimoto; Brett Zirkle; Xiaojiang S Chen
Journal:  Nucleic Acids Res       Date:  2017-07-07       Impact factor: 16.971

9.  A Tumor-Promoting Phorbol Ester Causes a Large Increase in APOBEC3A Expression and a Moderate Increase in APOBEC3B Expression in a Normal Human Keratinocyte Cell Line without Increasing Genomic Uracils.

Authors:  Sachini U Siriwardena; Madusha L W Perera; Vimukthi Senevirathne; Jessica Stewart; Ashok S Bhagwat
Journal:  Mol Cell Biol       Date:  2018-12-11       Impact factor: 5.069

View more
  1 in total

1.  Quantification of APOBEC3 Mutation Rates Affecting the VP1 Gene of BK Polyomavirus In Vivo.

Authors:  Dorian McIlroy; Cécile Peltier; My-Linh Nguyen; Louise Manceau; Lenha Mobuchon; Nicolas Le Baut; Ngoc-Khanh Nguyen; Minh-Chau Tran; The-Cuong Nguyen; Céline Bressollette-Bodin
Journal:  Viruses       Date:  2022-09-19       Impact factor: 5.818

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.